๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Induction of pinocytosis in cerebral vessels by acute hypertension and by hyperosmolar solutions

โœ Scribed by Dr. Hans-Arne Hansson; Barbro B. Johansson

Publisher
John Wiley and Sons
Year
1980
Tongue
English
Weight
883 KB
Volume
5
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

โœฆ Synopsis

Abstract

A new approach is described to study the mechanism of protein leakage through the endothelial cells in acute hypertension and after intracarotid infusion of hyperosmolar solutions. The luminal surface of the cerebrovascular endothelial cells was labeled with choleragenoidโ€peroxidase before the bloodโ€brain barrier (BBB) dysfunction was induced. Numerous pinocytotic vesicles and some transโ€endothelial channels were formed and showed labeling of parts of their membranes.

Our results indicate that the mechanism behind the protein leakage induced by hypertension and by hyperosmolar solutions is the same โ€“ ie, transendothelial pinocytosis.

๐Ÿ“œ SIMILAR VOLUMES

Measurement of cytotoxic and interstitia
Measurement of cytotoxic and interstitial components of cerebral edema in acute hepatic failure by diffusion tensor imaging
โœ Vijan Rai; Kavindra Nath; Vivek A. Saraswat; Ankur Purwar; Ram K.S. Rathore; Rak ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 505 KB

## Abstract ## Purpose To use diffusion tensor imaging (DTI) metrics for measuring cytotoxic and interstitial components of cerebral edema (CE) in acute hepatic failure (AHF) patients. CE is a major complication in patients with AHF. ## Materials and Methods DTI was performed in 20 patients with

Worsening of cerebral hyperemia by the a
Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy
โœ Debbie L. Shawcross; Nathan A. Davies; Rajeshwar P. Mookerjee; Peter C. Hayes; R ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 117 KB ๐Ÿ‘ 1 views

There is increasing evidence that terlipressin is useful in patients with cirrhosis and hepatorenal syndrome, but there are no data of its use in patients with acute liver failure (ALF) in whom hepatorenal syndrome is common. Although terlipressin produces systemic vasoconstriction, it produces cere